Raymond Alexanian, MD, Oral History Interview, June 5, 2014
Files
Loading...
Description
Major Topics Covered:
- Committees at MD Anderson: Research Committee, Surveillance Committee, Transfusion Task Force, Faculty Classification Committee;
- The research and cultural environment of MD Anderson under Dr. R. Lee Clark;
- Changes with growth of MD Anderson;
- The impact of regulation on research and innovation
Interview Chapters
Chapter 11: Regulatory Procedures: A Critical View
Chapter 13: Mentoring Young Faculty in Research Flexibility and Writing Skills
Chapter 14: The Research Committee; The Surveillance Committee
Chapter 15: "The Research Report": an Innovative Communication Device for MD Anderson
Chapter 16: The Faculty Classification Committee and Related Issues with Tenure and Promotion
Chapter 17: The Patent Committee
Chapter 18: The Transfusion Task Force and National Transfusion Standards
Chapter 19: The Summer Students Program; Changes in MD Anderson Culture
Chapter 20: The Value of Committee Work; Changes in MD Anderson Culture and the Need for Mentoring
Identifier
AlexanianR_02_20140605
Publication Date
6-5-2014
Publisher
The Making Cancer History® Voices Oral History Collection, The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Alexanian, Raymond MD and Rosolowski, Tacey A. PhD, "Raymond Alexanian, MD, Oral History Interview, June 5, 2014" (2014). Interview Sessions. 18.
https://openworks.mdanderson.org/mchv_interviewsessions/18
Conditions Governing Access
Open
About the Interview
About the Interview Subject
Dr. Raymond Alexanian (b. 8 June 1932, Queens, New York) joined MD Anderson in 1964 as an Assistant Professor of Medicine and served as Section Chief of Myeloma for many years. He retired in 2013 and holds Emeritus status. Dr. Alexanian achieved a national reputation through his work on erythropoietin, then shifted his specialization to cancer and to myeloma. At MD Anderson he innovated combination therapies for the disease. In collaboration with Bart Barlogie, MD, PhD, he developed a treatment combining chemotherapy and stem cell transplantation. Most recently he has written on the difficulty of defining “cure” in myeloma. In 2001 he received the Waldenström Award for his work in myeloma research.